IBM's Earnings Beat Triggers Selloff as Wall Street Weighs AI Risk Against Mainframe Revival

IBM's strong Q1 revenue and earnings beat failed to lift the stock, as analyst targets diverge and consulting risks weigh on investor sentiment.

IBM delivered a standout first quarter, yet the market response tells a different story. The technology giant reported revenue of $15.92 billion for the three months ended March 2026, a 9.5% year-over-year increase that comfortably surpassed analyst expectations. Adjusted earnings per share of $1.91 also beat Wall Street forecasts by roughly 5.5%. But the stock has shed nearly 10% in the past week, trading around $226 — a level that leaves it close to its 12-month lows and roughly 22% below where it started the year.

The disconnect between operational performance and market sentiment has become a defining feature of IBM's current narrative. While the numbers are strong, investors are applying a more exacting lens to the company's valuation after a two-year restructuring push toward software. The operating margin improved to 11.7%, up from 10% in the prior-year period, while HSBC analyst Stephen Bersey noted that the non-GAAP operating margin of 15.7% landed roughly 85 basis points above consensus. Yet none of that prevented the selloff.

Analyst Targets Diverge as Dividend Hike Offers Little Comfort

The earnings release came with a dividend increase — shareholders will now receive $1.69 per share, translating to a yield of roughly 3% at current prices. But the move failed to stem the selling pressure. Meanwhile, analyst opinions on IBM's fair value have fractured. Citigroup initiated coverage with a Buy rating and a $285 target, while Morgan Stanley cut its price target to $225 and Wedbush lowered expectations to $320. The consensus among 15 analysts sits at $293, with some fair-value models pointing as high as $302 — implying significant upside from current levels.

HSBC upgraded IBM from Neutral to Hold with a $231 price target, and DZ Bank raised its rating to Buy. The Erste Group Bank also lifted its earnings estimates for 2027. But the divergence in near-term outlooks underscores the uncertainty gripping the stock.

Mainframe Surges as Consulting Remains a Question Mark

The strongest operational signal came from IBM's mainframe business, which jumped 51% in the first quarter. The software division grew 11%, and free cash flow reached $2.2 billion — CFO Jim Kavanaugh called it the highest first-quarter figure in a decade. The company's enterprise AI platform Watsonx is now used by 95% of Fortune 500 companies, and the mainframe system processes up to 450 billion AI inferences daily, with financial institutions deploying it for real-time fraud detection on every transaction.

But the consulting business continues to cast a shadow. The more companies adopt AI at scale, the greater the risk that they internalize traditional IT consulting work — a dynamic that could erode IBM's services revenue. The February selloff, when Anthropic suggested AI could help modernize COBOL code, sent the stock down 13% in a single day and highlighted how vulnerable the consulting narrative has become.

Confluent Integration Becomes the Next Test

The $11.6 billion acquisition of Confluent, completed in the first quarter, now becomes a critical proving ground. IBM needs to demonstrate that the data infrastructure business can offset any weakness in consulting. How smoothly the integration proceeds — and whether it delivers the anticipated synergies — will shape the valuation debate in the quarters ahead.

For now, the market is pricing in considerable skepticism. The stock trades at a steep discount to its average analyst target, but the path to closing that gap runs through consulting stabilization and successful M&A execution. IBM's technology story remains compelling, but the market wants proof that the narrative translates into sustained earnings growth.